Susquehanna International Group’s NOVONIX NVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.38K Sell
2,038
-12,031
-86% -$80.1K ﹤0.01% 13142
2026
Q1
$97.1K Sell
14,069
-7,793
-36% -$75.7K ﹤0.01% 12359
2025
Q4
$221K Buy
21,862
+16,770
+329% +$238K ﹤0.01% 10660
2025
Q3
$65.2K Buy
+5,092
New +$66.4K ﹤0.01% 11771
2025
Q2
– Sell
-1,269
Closed -$14.6K – 13402
2025
Q1
$14.6K Sell
1,269
-1,217
-49% -$17.2K ﹤0.01% 12181
2024
Q4
$44.7K Buy
+2,486
New +$48.2K ﹤0.01% 11725
2024
Q2
– Sell
-1,476
Closed -$33.8K – 12871
2024
Q1
$33.8K Buy
+1,476
New +$29.8K ﹤0.01% 11679

Other funds holding NVX

Susquehanna International Group's NVX Position: Q2 2026 in Review

Susquehanna International Group reduced its NOVONIX (NVX) stake by 86% in Q2 2026, selling an estimated $80.1K and leaving 2,038 shares worth $9.38K. The position accounts for ﹤0.01% of the portfolio, ranked #13142.

Susquehanna International Group first reported a position in NVX in Q1 2024 and has held it in 7 quarters since. The position peaked at $221K in Q4 2025. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Susquehanna International Group held 2,038 shares of NOVONIX worth $9.38K as of Q2 2026.
  • Susquehanna International Group sold 12,031 NOVONIX shares in Q2 2026, an estimated $80.1K.
  • NOVONIX made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13142 holding.
  • Susquehanna International Group first reported a position in NOVONIX in Q1 2024 and has held it in 7 quarters since.
  • Susquehanna International Group's NOVONIX position peaked at $221K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.